HCmed Innovations Co (ROCO:6934) Cash And Cash Equivalents : NT$65.8 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is HCmed Innovations Co Cash And Cash Equivalents?

HCmed Innovations Co's quarterly cash and cash equivalents declined from Dec. 2023 (NT$66.61 Mil) to Jun. 2024 (NT$60.48 Mil) but then increased from Jun. 2024 (NT$60.48 Mil) to Dec. 2024 (NT$65.83 Mil).

HCmed Innovations Co's annual cash and cash equivalents declined from Dec. 2022 (NT$123.50 Mil) to Dec. 2023 (NT$66.61 Mil) and declined from Dec. 2023 (NT$66.61 Mil) to Dec. 2024 (NT$65.83 Mil).

HCmed Innovations Co Cash And Cash Equivalents Historical Data

The historical data trend for HCmed Innovations Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HCmed Innovations Co Cash And Cash Equivalents Chart

HCmed Innovations Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Cash And Cash Equivalents

48.49

123.50

66.61

65.83

HCmed Innovations Co Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash And Cash Equivalents	Get a 7-Day Free Trial			123.50	56.13	66.61	60.48	65.83

HCmed Innovations Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

HCmed Innovations Co (ROCO:6934) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

HCmed Innovations Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of HCmed Innovations Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

HCmed Innovations Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HCmed Innovations Co Ltd (ROCO:6934) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033

Website

https://www.hcmed-inno.com

HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine.

HCmed Innovations Co Headlines

No Headlines